3-Hydroxy-2-(pyridin-4-yl)-1H-inden-1-one, 95.0%, 250mg

2,5-Difluorobenzyl Chloride>98.0%(GC)25g

2-(5-Norbornene-2,3-dicarboximido)-1,1,3,3-tetramethyluronium Tetrafluoroborate [Coupling Reagent for Peptide]>96.0%(N)5g

1-(BENZYLOXY)-2-METHYLPROPAN-2-OL, 95%, 250mg

N-Boc-S-benzyl-D-cysteine, 95.0%, 10g

2-(Furan-2-yl)acetonitrile, 95+%, 1g

(25-35% Methylethylhydrosiloxane)-dimethylsiloxane copolymer, trimethylsiloxane terminated, reduced volatility, 100g

o-Phenetidine>98.0%(GC)500g

2-Methyl-4-pyrimidinamine, 98.0%, 1g

6-CHLOROQUINOLIN-2(1H)-ONE, 97.0%, 5g

Hexaméthylènetétramine, min 99%, ultra pur, 500 g, emballage plastique.

5-Isobutyl-1,2,4-oxadiazole-3-carboxylic acid, 95%, 2.5g

7-Bromo-1-methyl-1,3-dihydro-2H-benzo[d]imidazol-2-one, 97%, 10g